Analytical Data
-
基因名
CEACAM1
- Application
-
别名
CEACAM1；BGP；BGP1；Carcinoembryonic antigen-related cell adhesion molecule 1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P13688
-
表达区间
35-428aa
-
氨基酸序列
QLTTESMPFNVAEGKEVLLLVHNLPQQLFGYSWYKGERVDGNRQIVGYAI GTQQATPGPANSGRETIYPNASLLIQNVTQNDTGFYTLQVIKSDLVNEEA TGQFHVYPELPKPSISSNNSNPVEDKDAVAFTCEPETQDTTYLWWINNQS LPVSPRLQLSNGNRTLTLLSVTRNDTGPYECEIQNPVSANRSDPVTLNVT YGPDTPTISPSDTYYRPGANLSLSCYAASNPPAQYSWLINGTFQQSTQEL FIPNITVNNSGSYTCHANNSVTGCNRTTVKTIIVTELSPVVAKPQIKASK TTVTGDKDSVNLTCSTNDTGISIRWFFKNQSLPSSERMKLSQGNTTLSIN PVKREDAGTYWCEVFNPISKNQSDPIMLNVNYNALPQENGLSPGVDHHHH HH
-
分子量
44 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CEACAM1 (Carcinoembryonic Antigen-related Cell Adhesion Molecule 1) is a member of the CEACAM family of proteins, which are involved in various biological processes, including cell adhesion, immune response, and tumor progression. Its expression is often upregulated in various tumors, making it a potential biomarker for cancer diagnosis and therapy. The study of CEACAM1 recombinant protein has attracted significant attention due to its critical role in mediating interactions between immune cells and tumor cells, influencing cancer metastasis and immune evasion. Research has shown that CEACAM1 can modulate T cell responses and angiogenesis, further emphasizing its potential as a therapeutic target. Furthermore, understanding the structural and functional properties of CEACAM1 through recombinant protein production can provide insights into its mechanisms of action, paving the way for the development of CEACAM1-based therapeutics and diagnostic tools. As researchers seek to harness its properties for clinical applications, generating high-quality recombinant CEACAM1 is essential for studying its interactions and effects in both preclinical and clinical settings. Overall, CEACAM1 stands out as a significant protein in cancer biology, making its recombinant form a valuable resource for further exploration in the fields of immunology and oncology.
